Frequency, | HAQ | HAQ | SHS progression baseline to year 10 | |
---|---|---|---|---|
n (%) patients | year 2 to year 10 | at year 10 | ||
Total n = 480 | median (IQR) | median (IQR) | median (IQR) | |
No. of flare A | ||||
0 | 159 (33) | 0.2 (0.0–0.6) | 0.0 (0.0–0.5) | 1.3 (0.0–3.1) |
1 | 100 (21) | 0.5 (0.2–0.9) | 0.4 (0.0–0.9) | 2.3 (0.5–9.6) |
2 | 73 (15) | 0.6 (0.3–0.9) | 0.6 (0.1–0.9) | 3.0 (0.0–10.0) |
≥3 | 148 (31) | 0.8 (0.4–1.1) | 0.8 (0.4–1.3) | 4.3 (0.5–20.1) |
p value | <0.001 | <0.001 | 0.005 | |
No. of minor flare B | ||||
0 | 321 (67) | 0.4 (0.1–0.8) | 0.3 (0.0–0.9) | 2.0 (0.0–6.9) |
1 | 89 (19) | 0.6 (0.4–1.0) | 0.6 (0.3–1.0) | 6.0 (0.5–26.0) |
2 | 37 (8) | 0.7 (0.3–1.1) | 0.8 (0.3–1.1) | 4.5 (0.1–26.8) |
≥3 | 33 (7) | 0.9 (0.6–1.1) | 0.8 (0.4–1.3) | 1.0 (0.0–13.5) |
p value | <0.001 | <0.001 | 0.026 | |
No. of major flare B | ||||
0 | 176 (37) | 0.3 (0.0–0.8) | 0.0 (0.0–0.8) | 1.5 (0.0–3.5) |
1 | 114 (24) | 0.5 (0.2–0.9) | 0.4 (0.0–0.9) | 2.0 (0.5–10.3) |
2 | 68 (14) | 0.6 (0.3–0.9) | 0.6 (0.1–0.9) | 3.5 (0.5–17.0) |
≥3 | 122 (25) | 0.8 (0.4–1.1) | 0.8 (0.3–1.1) | 4.5 (0.3–17.3) |
p value | <0.001 | <0.001 | 0.009 |